17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Excessive scar formation caused by myofibroblast aggregations is of great clinical importance during skin wound healing. Umbilical cord-derived mesenchymal stem cells (uMSCs) reduced scar formation and myofibroblast accumulation in a skin-defect mouse model. A novel role of exosomal microRNAs in uMSC-mediated therapy was demonstrated, suggesting that the clinical application of uMSC-derived exosomes might represent a strategy to prevent scar formation during wound healing.

          Abstract

          Excessive scar formation caused by myofibroblast aggregations is of great clinical importance during skin wound healing. Studies have shown that mesenchymal stem cells (MSCs) can promote skin regeneration, but whether MSCs contribute to scar formation remains undefined. We found that umbilical cord-derived MSCs (uMSCs) reduced scar formation and myofibroblast accumulation in a skin-defect mouse model. We found that these functions were mainly dependent on uMSC-derived exosomes (uMSC-Exos) and especially exosomal microRNAs. Through high-throughput RNA sequencing and functional analysis, we demonstrated that a group of uMSC-Exos enriched in specific microRNAs (miR-21, -23a, -125b, and -145) played key roles in suppressing myofibroblast formation by inhibiting the transforming growth factor-β2/SMAD2 pathway. Finally, using the strategy we established to block miRNAs inside the exosomes, we showed that these specific exosomal miRNAs were essential for the myofibroblast-suppressing and anti-scarring functions of uMSCs both in vitro and in vivo. Our study revealed a novel role of exosomal miRNAs in uMSC-mediated therapy, suggesting that the clinical application of uMSC-derived exosomes might represent a strategy to prevent scar formation during wound healing.

          Significance

          Exosomes have been identified as a new type of major paracrine factor released by umbilical cord-derived mesenchymal stem cells (uMSCs). They have been reported to be an important mediator of cell-to-cell communication. However, it is still unclear precisely which molecule or group of molecules carried within MSC-derived exosomes can mediate myofibroblast functions, especially in the process of wound repair. The present study explored the functional roles of uMSC-exosomal microRNAs in the process of myofibroblast formation, which can cause excessive scarring. This is an unreported function of uMSC exosomes. Also, for the first time, the uMSC-exosomal microRNAs were examined by high-throughput sequencing, with a group of specific microRNAs (miR-21, miR-23a, miR-125b, and miR-145) found to play key roles in suppressing myofibroblast formation by inhibiting excess α-smooth muscle actin and collagen deposition associated with activity of the transforming growth factor-β/SMAD2 signaling pathway.

          Related collections

          Author and article information

          Journal
          Stem Cells Transl Med
          Stem Cells Transl Med
          Stem Cells Translational Medicine
          sctm
          Stem Cells Translational Medicine
          Stem Cells Translational Medicine
          AlphaMed Press (Durham, NC, USA )
          2157-6564
          2157-6580
          October 2016
          07 July 2016
          1 October 2017
          : 5
          : 10
          : 1425-1439
          Affiliations
          [ a ]Department of Plastic and Reconstruction, Shanghai Changhai Hospital Affiliated to Second Military Medical University, Shanghai, People’s Republic of China
          [ b ]Department of Spinal Surgery, Changzheng Hospital Affiliated to Second Military Medical University, Shanghai, People’s Republic of China
          [ c ]Department of Emergency and Trauma, Shanghai Changhai Hospital Affiliated to Second Military Medical University, Shanghai, People’s Republic of China
          [ d ]Department of Microbiology, Shanghai Key Laboratory of Medical Biodefense, Second Military Medical University, Shanghai, People’s Republic of China
          [ e ]Research Center of Developmental Biology, Second Military Medical University, Shanghai, People’s Republic of China
          [ f ]Translational Medicine Center, Second Military Medical University, Shanghai, People’s Republic of China
          Author notes
          Correspondence: Xin Xing, M.D., Ph.D., Department of Plastic and Reconstruction, Shanghai Changhai Hospital Affiliated to Second Military Medical University, 168th Chang Hai Road, Shanghai 200433, People’s Republic of China. Telephone: 86-021-3116-1811; E-Mail: mone1030@ 123456163.com ; or Yue Wang, Ph.D., Research Center of Developmental Biology and Translational Medicine Center, Second Military Medical University, 800th Xiangyin Road, Shanghai 200433, People’s Republic of China. Telephone: 86-021-8187-0964; E-Mail: wangyuesmmu@ 123456163.com ; or Houqi Liu, Ph.D., Research Center of Developmental Biology and Translational Medicine Center, Second Military Medical University, 800th Xiangyin Road, Shanghai 200433, People’s Republic of China. Telephone: 86-021-8187-0958; E-Mail: houqiliu@ 123456126.com
          [*]

          Contributed equally.

          Article
          PMC5031180 PMC5031180 5031180 20150367
          10.5966/sctm.2015-0367
          5031180
          27388239
          46ed7fe3-08c3-4576-a64f-71b82a9d38cb
          ©AlphaMed Press
          History
          : 25 November 2015
          : 18 April 2016
          Page count
          Figures: 7, Tables: 0, Equations: 0, References: 42, Pages: 15
          Categories
          11
          18
          35
          Tissue Engineering and Regenerative Medicine
          Custom metadata
          v1

          Myofibroblast,Transforming growth factor-β,Exosome,Mesenchymal stem cells,MicroRNA

          Comments

          Comment on this article